[1] DINLEYICI M, BARBIEUR J, DINLEYICI E C, et al. Functional effects of human milk oligosaccharides (HMOs) [J]. Gut Microbes, 2023, 15: 2186115. [2] 张卓星, 徐慧慧, 刘汝薇, 等. 母乳及牛乳低聚糖组成、含量及功能的研究进展[J]. 食品科学, 2024, 45(24): 302-315. [3] URASHIMA T, HIRABAYASHI J, SATO S, et al. Human milk oligosaccharides as essential tools for basic and application studies on galectins[J]. Trends Glycosci Glycotechnol, 2018, 30(172): SE51-SE65. [4] 王司琪, 张宇, 彭小雨, 等. 母乳中的活性成分: HMOs对机体的益处及应用现状[J]. 食品研究与开发, 2025, 46(6): 191-196. [5] TARRANT I, FINLAY B B. Human milk oligosaccharides: potential therapeutic aids for allergic diseases[J]. Trends Immunol, 2023, 44(8): 644-661. [6] BODE L. Human milk oligosaccharides: Every baby needs a sugar Mama[J]. Glycobiology, 2012, 22(9): 1147-1162. [7] 姜毅康, 董玲, 刘鸿飞, 等. 母乳低聚糖与婴幼儿健康关系研究进展[J]. 食品与机械, 2024, 40(2): 1-8. [8] PLAZA-DíAZ J, FONTANA L, GIL A. Human milk oligosaccharides and immune system development[J]. Nutrients, 2018, 10(8): 1038. [9] GOEHRING K C, MARRIAGE B J, OLIVER J S, et al. Similar to those who are breastfed, infants fed a formula containing 2'-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial[J]. J Nutr, 2016, 146(12): 2559-2566. [10] PUCCIO G, ALLIET P, CAJOZZO C, et al. Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial[J]. J Pediatr Gastroenterol Nutr, 2017, 64(4): 624-631. [11] 刘丹, 孙柳, 赵春华, 等. 母乳低聚糖LNnT和LNT的研究进展及法规市场情况概述[J]. 中国食品添加剂, 2024, 35(8): 230-240. [12] ZUMPANO BRUCIA D L. Human milk oligosaccharide L-N-tetraose activates GPR35 on vagal afferent neurons in vitro and reduces high fat diet-induced obesity in male mice[J]. FASEB J, 2022, 36(S1): R5855. [13] U.S. Food and Drug Administration. GRAS notice for lactoN-tetraose (LNT) [EB/OL]. (2020-04-13). https: //hfpappexternal. fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=833. [14] EFSA Panel on Nutrition, Novel Foods and Food Allergens, TURCK D, CASTENMILLER J, et al. Safety of lacto-Ntetraose (LNT) as a novel food pursuant to Regulation (EU) 2015/2283[J]. EFSA J, 2019, 17(12): e05907. [15] EFSA Panel on Nutrition, Novel Foods and Food Allergens, TURCK D, BOHN T, et al. Safety of lacto-N-tetraose (LNT) produced by derivative strains of Escherichia coli BL21(DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283[J]. EFSA J, 2022, 20(5): e07242. |